US2011183034A1PendingUtilityA1

Enhancement of magenesium uptake in mammals

Assignee: JAFFE RUSSELLPriority: Aug 15, 2003Filed: Apr 8, 2011Published: Jul 28, 2011
Est. expiryAug 15, 2023(expired)· nominal 20-yr term from priority
Inventors:Russell Jaffe
A61P 9/06A61K 33/06A61K 31/13A61P 3/02A61K 31/685A61K 31/19
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are methods and complexes for increasing magnesium uptake in mammals. Increasing magnesium uptake in mammals is accomplished by concurrently administering one or more magnesium salts with one or more quaternary amines and/or phosphatides and one or more di- or tri-carboxylic acids.

Claims

exact text as granted — not AI-modified
1 . A magnesium complex comprising:
 a magnesium salt;   a quaternary amine or phosphatide; and   a di-carboxylic acid or tri-carboxylic acid.   
     
     
         2 . The magnesium complex of  claim 1 , wherein the complex further comprises water or glycerol. 
     
     
         3 . The magnesium complex of  claim 1 , wherein the complex further comprises a solution of water and glycerol. 
     
     
         4 . The magnesium complex of  claim 1 , wherein the magnesium salt is chosen from the group consisting of magnesium glycinate, magnesium ascorbate, magnesium chloride, magnesium sulfate, magnesium orotate, magnesium citrate, magnesium fumarate, magnesium malate, magnesium succinate, magnesium tartrate and magnesium carbonate or similar magnesium salt. 
     
     
         5 . The magnesium complex of  claim 1 , comprising the phosphatide choline. 
     
     
         6 . The magnesium complex of  claim 1 , comprising the di-carboxylic acid citrate. 
     
     
         7 . A method for enhancing magnesium uptake in mammals comprising: administering to a mammal a magnesium salt, a quaternary amine or phosphatide and a di-carboxylic acid or tri-carboxylic acid. 
     
     
         8 . The method of  claim 7 , wherein the administering is oral. 
     
     
         9 . The method of  claim 7 , wherein the magnesium salt, the quaternary amine or phosphatide and the di-carboxylic acid or tri-carboxylic acid are in a water and glycerol solution. 
     
     
         10 . The method of  claim 7 , wherein the magnesium salt is chosen from the group consisting of magnesium glycinate, magnesium ascorbate, magnesium chloride, magnesium sulfate, magnesium orotate, magnesium citrate, magnesium fumarate, magnesium malate, magnesium succinate, magnesium tartrate and magnesium carbonate or similar magnesium salt. 
     
     
         11 . The method of  claim 7 , comprising the phosphatide choline. 
     
     
         12 . The method of  claim 7 , comprising the tri-carboxylic acid citrate. 
     
     
         13 . The method of  claim 7 , wherein the mammal is a human. 
     
     
         14 . The method of  claim 7 , wherein the magnesium salt, the quaternary amine or phosphatide and the di-carboxylic acid or tri-carboxylic acid are administered together.

Join the waitlist — get patent alerts

Track US2011183034A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.